GGrantIndex
Sort

261,768 grants matching gene therapy

Foamy Viral Gene Therapy for X-linked Severe Combined Immune Deficiency

$2,468,421
David J Rawlings · Seattle Children'S Hospital · P01 · FY2016 · AI

Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.

$2,468,344
Todd C. Skaar · Indiana University Indianapolis · U01 · FY2020 · HG

Overcoming Drug Resistance in Multiple Myeloma

$2,468,281
Alexander Keith Stewart · Mayo Clinic Arizona · U54 · FY2017 · CA

Molecular Diagnostics Core Laboratory

$2,468,096
Liqiang Xi · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA

Targeting Myeloid Metabolism to Reprogram the Tumor Microenvironment of Glioblastoma

$2,467,799
Alexander H. Stegh · Washington University · R01 · FY2025 · CA

Cancer Center Support Grant

$2,467,468
Thomas P Loughran · University Of Virginia · P30 · FY2015 · CA

Septhohippocamal connectome dysfunction in Down syndrome associated with Alzheimer’s disease pathophysiology

$2,466,001
Stephen D. Ginsberg · New York University School Of Medicine · RF1 · FY2023 · AG

GENE THERAPY FOR SICKLE CELL ANEMIA

$2,465,735
Albert Einstein Col Of Med Yeshiva Univ · P01 · FY2004 · HL

Harnessing the Power of Experimental Genetic Crosses to Probe Drug Resistance in Malaria

$2,465,529
Michael T Ferdig · University Of Notre Dame · P01 · FY2025 · AI

SPORE in Head and Neck Cancer

$2,464,795
David Sidransky · Johns Hopkins University · P50 · FY2006 · CA

Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit

$2,464,363
Pablo Tebas · University Of Pennsylvania · UM1 · FY2020 · AI

Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses

$2,464,333
James E Crowe · University Of Texas Med Br Galveston · U19 · FY2023 · AI

HPMI: Host Pathogen Mapping Initiative

$2,464,183
Nevan J Krogan · University Of California, San Francisco · U19 · FY2025 · AI

Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial

$2,464,155
Parambir Singh Dulai · Northwestern University At Chicago · U01 · FY2025 · DK

Development of Novel Therapies for HIV Infection and AIDS-Related Malignancies

$2,463,925
Robert Yarchoan · Clinical Sciences · Z01 · FY2007 · CA

Novel Gene Networks in Breast Development and Cancer

$2,463,043
Baylor College Of Medicine · P01 · FY2005 · CA

Defining regulators of immunity to acute infection using CRISPR screens

$2,462,939
Arlene H Sharpe · Harvard Medical School · U19 · FY2017 · AI

Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV

$2,461,914
Manolis Kellis · Broad Institute, Inc. · U01 · FY2021 · DA

Estrogen's Impact on IgG Glycomic Modulation of Immunity and Inflammation During HIV

$2,461,651
Jordan E Lake · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · AI

"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"

$2,461,361
Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2016 · HG

Genome-wide Search for CVD Gene-Environment Interactions

$2,461,109
University Of Maryland Baltimore · U01 · FY2003 · HL

Experimental Therapy for Brain Tumors

$2,461,078
John H Sampson · Duke University · P01 · FY2019 · CA

Molecular Analysis Of Leukocyte Activation By Chemoattractants

$2,461,018
Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Neuronal anatomy, connectivity, and phenotypic innervation of the knee joint

$2,460,714
Brendan Hl Lee · Baylor College Of Medicine · UC2 · FY2025 · AR

PRECLINICAL MODELS OF ORGAN AND CELL TRANSPLANTATION TOL

$2,459,716
University Of Alabama At Birmingham · U19 · FY2002 · DK